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ABSTRACT
Cellular lesions form in Bowman’s space in both crescentic glomerulonephritis and collapsing glomeru-
lopathy. The pathomechanism and origin of the proliferating cells in these lesions are unknown. In this
study, we examined proliferating cells by lineage tracing of either podocytes or parietal epithelial cells
(PECs) in the nephrotoxic nephritis model of inflammatory crescentic glomerulonephritis. In addition, we
traced the fate of genetically labeled PECs in the Thy-1.1 transgenic mouse model of collapsing
glomerulopathy. In both models, cellular bridges composed of PECs were observed between Bowman’s
capsule and the glomerular tuft. Genetically labeled PECs also populated larger, more advanced cellular
lesions. In these lesions, we detected de novo expression of CD44 in activated PECs. In contrast, we
rarely identified genetically labeled podocytes within the cellular lesions of crescentic glomerulonephri-
tis. In conclusion, PECs constitute the majority of cells that compose early extracapillary proliferative
lesions in both crescentic glomerulonephritis and collapsing glomerulopathy, suggesting similar patho-
mechanisms in both diseases.
J Am Soc Nephrol 20: 2604–2615, 2009. doi: 10.1681/ASN.2009010122
Glomerular epithelial hyperplasia is an important
characteristic of crescentic glomerulonephritis
(CrGN), also known as rapidly progressive glomer-
ulonephritis. Despite a wide variety of underlying
causes, CrGN is characterized commonly by the de-
velopment of cellular crescents (multilayered accu-
mulation of cells in Bowman’s space) and necrosis
of glomerular capillaries.1 Loss of renal function oc-
curs as a consequence of the obstruction of the tu-
bular outlet by cellular crescents, so the proliferat-
ing cells present an important target for therapeutic
interventions.2
Collapsing glomerulopathy (CG) is character-
ized by massive proteinuria and rapid progressive
renal insufficiency and histologically by segmental
to global collapse of the capillary tuft and pro-
nounced epithelial cell hyperplasia.3 This pattern
has been described in HIV-associated nephropa-
thy,4 parvovirus B19 infection,5 and pamidronate
toxicity6 and also as an idiopathic form.3
The pathomechanismof the development of cel-
lular lesions remains to be established, and in both
CrGN and CG the origin of the hyperplastic cells
within cellular lesions has been a matter of debate.
In CrGN, the cellular composition of crescents ap-
pears to change over time, with predominantly ep-
ithelial cells of unknown origin proliferating in
early stages and increasing numbers of infiltrating
macrophages, lymphocytes, and myofibroblasts in
later stages, especially when Bowman’s capsule is
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ruptured.7–9 Recent studies also pointed to a contribution of
podocytes in the development of crescentic lesions.10–13 Col-
lapsing glomerulopathy lesions in turn often are associated
with hyperplasia of epithelial cells covering the glomerular tuft,
although connections to Bowman’s capsule appeared to be
lacking. The visceral localization and the finding that these
proliferating cells lacked expression of podocytemarkers led to
the concept of dysregulated podocytes, which are no longer
growth restricted, causing epithelial hyperplasia.14 However,
from the findings that these cells expressed markers normally
expressed by PECs15 and the finding in serial sections that the
cells on the tuft were connected to the PECs on Bowman’s
capsule,16 we and others suggested that these cells may origi-
nate from parietal epithelial cells (PECs) rather than from
podocytes.16–20
In the studies described above, the origin of the proliferat-
ing cells was identified based on the expression or loss of spe-
cific markers. This approach may be misleading, given that,
first, PECs and podocytes share a common embryonic origin.
Only during the last stages of nephrogenesis the phenotypes of
both cells diverge. Second, PECs lack specific differentiation
markers, and third, proliferating cellsmay possibly transdiffer-
entiate into cells with a different phenotype. Genetic cell lin-
eage tracing is a technique that has been established recently
and enables one to trace cells over prolonged times, even when
the cells switch to a different phenotype due to de- or transdif-
ferentiation.19,21 In the present study, we therefore used this
technique to trace the relative contributions of PECs and
podocytes in the development of cellular glomerular lesions in
two murine models of CrGN, namely, nephrotoxic nephritis,
and CG, namely, Thy-1.1 transgenic mice. These established
murinemodelswere chosen because both characteristically de-
velop proliferative extracapillary lesions.
RESULTS
Histopathology of the Crescentic Glomerulonephritis
Model
Injection of the nephrotoxic serum (NTS) serum induced pro-
teinuria and hematuria within the first day or three days after
injection, respectively. The renal histology of NTS-injected
mice was examined at day 14 after the induction of CrGN. At
this time point, “true” crescents (organized multilayered epi-
thelial lesions lining Bowman’s capsule) were observed (Figure
1, A and B). Between the cell layers, accumulation of extracel-
Figure 1. Histology of the CrGN model. (A–D) PAS stainings of the CrGN model at day 14 after anti-nephrotoxic serum injection. Light
microscopy revealed pronounced hyperplasia of glomerular epithelial cells, forming organized multilayered true crescentic lesions (A
and B, arrows) and less organized pseudocrescents and monolayer lesions on the glomerular tuft (C and D, arrowheads). Marked
periglomerular fibrosis was seen in the regions surrounding affected glomeruli (A, yellow arrow). An occasional infiltrative inflammatory
cell (C, red arrow, polymorphonuclear leukocyte) or protein accumulation (A, asterisks) could be observed within the cellular lesions.
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lular matrix was present. In addition to the “true” crescents,
many glomeruli contained “pseudocrescents” consisting of
one ormore layers of proliferating polygonal cells located close
to or on the glomerular tuft (Figure 1, C and D). Within the
capillaries, hyalinosis was present. Marked periglomerular fi-
brosis was seen in the regions surrounding affected glomeruli.
Tracing Genetically Tagged Parietal Cells in Crescentic
Glomerulonephritis
To test whether PECs contribute to the formation of cellular
crescents, PECs were labeled genetically in triple transgenic
PEC-Reverse Tetracycline-Transactivator (rtTA)/LC1/Rosa 26
reporter (R26R) mice by doxycycline administration for 14 d.
After doxycycline administration, Cre recombination oc-
curred inmore than 70%of all PECs and could be visualized by
enzymatic X-gal staining (Figure 2, A and B). After genetic
labeling and a washout period of at least one week, the PEC-
rtTAmice were injected with the nephrotoxic serum to induce
CrGN. At day 14 after CrGN induction, X-gal staining per-
sisted in PECs lining Bowman’s capsule. In affected glomeruli,
crescentic lesions contained numerous X-gal positive cells
(Figure 3A). Pseudocrescents and monolayer lesions attached
to or covering glomerular tuft segments were also X-gal posi-
tive (Figure 3, B and C). Monolayer lesions were associated
with an adhesion between Bowman’s capsule and the glomer-
ular tuft, providing the presumptive entry site for genetically
tagged parietal cells onto the capillary convolute. Single X-gal
or Bluo-gal positive PECs were observed regularly that were
attached to the glomerular tuft, forming cellular bridges be-
tween Bowman’s capsule and the glomerular tuft (Figure 3D).
De Novo Expression of CD44 in Activated Parietal Cells
First, we determined whether the PECmarker claudin-1 could
still be used to identify PECs within crescentic lesions. For this
purpose, we detected the -gal expression using Bluo-gal, which
typically yields only a few granular particles per stained cell, and
Figure 2. Genetic tagging of podocytes or PECs in
triple transgenic doxycycline-inducible mouse lines. (A)
The modified rabbit podocalyxin promoter (PEC pro-
moter) drives expression of the enhanced tetracycline
reverse transactivator (rtTA-M2) as described previous-
ly.22 The podocyte-specific Pod-rtTA transgenic mice
were kindly provided by Jeffrey Kopp, Massachusetts
Institute of Technology, Cambridge, MA.35 Both mice
were mated with LC1 mice expressing Cre recombinase
(and luciferase) under the control of tetracycline respon-
sive elements (TREs), which can be activated by the tran-
scription factor rtTA-M2 in the presence of doxycycline.
The R26R mice were used as a reporter line, which irre-
versibly expresses -galactosidase (LacZ) under the con-
trol of the ubiquitously active Rosa26 locus only after Cre
excision of an interposed floxed neomycin cassette (neo,
acting as a stop signal) has occurred. These matings re-
sulted in the triple transgenic PEC-rtTA/LC1/R26R (to tag
parietal cells) and POD-rtTA/LC1/R26R mice (to tag
podocytes). For studies in the CG model, the PEC-rtTA/
LC1/R26R mice were mated to the Thy-1.1 transgenic
mouse line (T6 clone).37 (B) Genetic labeling of PECs
using doxycycline at the age of 4 wk in triple transgenic
PEC-rtTA/LC1/R26R mice. After induction, Cre recombi-
nation occurred in more than 70% of all PECs (arrow-
heads, labeled PEC). Sporadic labeling was observed in
some tubular cells of the renal cortex (not shown). (C)
Genetic labeling of podocytes using doxycycline at the
age of 4 wk in triple transgenic Pod-rtTA/LC1/R26R mice.
After induction, Cre recombination occurred in more than
70% of all podocytes, similar to the PEC-rtTA mice (ar-
rowheads, labeled podocytes; arrow, unlabeled tuft
segment).
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subsequently stained the sectionwithanantibodydirectedagainst
claudin-1 (in red). In nonaffected glomeruli, claudin-1 was ex-
pressed exclusively by PECs lining Bowman’s capsule.22,23 In
CrGN, the crescentic lesions also stained positive for claudin-1.
Manyof the claudin-1positive cellswithin the crescentic lesionor
lining Bowman’s capsule showed costaining with Bluo-gal (Fig-
ure 3, D and E). Next, we examined the expression of CD44. In
controlmice, we did not observe CD44 expression in the glomer-
ulus, asdescribed in the literature;24 however, in theCrGNmodel,
CD44 was expressed de novo in affected glomeruli. CD44 was ex-
pressed by cells in the areas of interstitial and periglomerular fi-
brosis andwithin the crescentic lesion. CD44 colocalizedwith the
X-galpositive cells liningBowman’s capsule and forming thecres-
centic lesions (Figure 3, F and G).
Tracing Genetically Tagged Podocytes in Crescentic
Glomerulonephritis
To examine whether and to what extent podocytes also con-
tribute to the formation of cellular crescents, triple transgenic
POD-rtTA/LC1/R26R mice were labeled genetically by doxy-
cycline administration. Similar to the PEC labeling in the PEC-
rtTA mice, Cre recombination occurred in more than 70% of
all target cells (arrow in Figure 2C shows an unlabeled tuft
segment). Oneweek after termination of the doxycycline treat-
Figure 3. Genetically labeled PECs are present within crescentic lesions. (A–C) The PECs that were tagged genetically after
doxycycline administration in PEC-rtTA/LC1/R26R mice were traced in crescentic lesions. True crescentic lesions (A), pseudocre-
scents (B), and monolayer lesions (C) observed at day 14 after the NTS injection stained positive with X-gal, confirming their origin
from the parietal epithelial compartment (arrows). A cross section of the glomerular tuft is seen separating the monolayer lesion
and Bowman’s capsule in C (arrowhead). (D) -Gal expressing cells (stained using Bluo-Gal, resulting in intracellular blue particles)
frequently formed cell bridges between Bowman’s capsule and the glomerular tuft (D, arrow). The Bluo-gal expressing cells
showed colocalization with the PEC marker claudin-1 (D, arrow; E, arrowhead). Within monolayer (F, arrow) and crescentic lesions
(G, arrows), the X-gal positive cells stained for CD44. Note that CD44 also is expressed by the cells present in the periglomerular
fibrotic region (F and G, arrowheads).
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ment, the POD-rtTAmice were injected
with the nephrotoxic serum to induce
CrGN. At day 14 after CrGN induction,
the morphologically normal glomeruli
within the kidneys with CrGN showed
normal X-gal staining exclusively of
podocytes. In affected glomeruli, seg-
mental loss of -gal expression was ob-
served. Specifically, the areas of the glo-
merular tuft involved in glomerular
crescents were X-gal negative.
None or only a few cells stained pos-
itive for X-gal within the hyperplastic le-
sions covering the glomerular tuft or fill-
ing up Bowman’s space (Figure 4, A–C,
arrows). In those cases where X-gal pos-
itive cells were involved in the lesions,
the cells could be observed predomi-
nantly along the periphery of the lesion
(Figure 4D, arrows).
To analyze the nature of the X-gal
negative segments within the glomerular
tuft, the slides were costained with X-gal
and ASD33, an antibody directed specifi-
cally against podocytes. In these double
stainings, the X-gal and podocyte marker
staining overlapped (Figure 4C). Both X-
gal andASD33were expressed in themor-
phologically normal tuft segments but lost
in the segments that were involved in the
crescentic lesions (arrow).Conversely, ina
costaining of X-gal with claudin-1 and
CD44, it could be established that the X-
gal negative areas were covered with clau-
din-1 (Figure 4, A, B, and E) and CD44
(Figure 4F) positive cells, presumably rep-
resenting PECs. It was concluded, that pa-
rietal cells invade and overgrow the glo-
merular tuft using cellular adhesions as
entry sites.
To evaluate the relative contributions
of tagged podocytes and PECs to the cres-
centic lesions, we quantified the percent-
agesof crescentic lesions that containedei-
ther X-gal stained podocytes or PECs. However, in X-gal stained
sections that were counterstained with eosin, small hyperplastic
lesions in Bowman’s capsulewere difficult to detect and therefore
could be missed. We therefore looked for a marker that can be
used to also detect early crescentic lesions. To this end, we exam-
ined how CD44 expression correlated with the pathological
changes in the glomeruli by performing CD44 immunostainings
in combinationwith periodic acid–Schiff (PAS) staining. Inmor-
phologically normal glomeruli, there was either no CD44 expres-
sion or de novo expression by the PECs lining Bowman’s capsule,
indicating activation of PECs as shown above (Figure 5A). Strik-
ingly, we found that 100% of the crescentic lesions (pseudo- and
true crescents) visible in the PAS staining were positive for CD44
(Figure 5, B–D), indicating that CD44 is a good marker for the
presence of crescentic lesions. To evaluate the contribution of
tagged podocytes and PECs, we analyzed the X-gal–CD44 double
staining and found that 85 8% of the crescentic lesions in the
PEC-rtTAmice contained X-gal positive PECs. In the POD-rtTA
mice, we found that in 13  9% of the crescentic lesions X-gal
positive podocytes were involved. Only in the PEC-rtTA mouse
intracellular colocalization of X-gal and CD44 in cells was de-
tected.
Figure 4. Genetically labeled podocytes are excluded from crescentic lesions. (A, B)
Double staining with X-gal and claudin-1 revealed no costaining in the -gal expressing
cells. Genetic labeling persisted in podocytes. But the crescentic lesions in Bowman’s
space that stain positive for claudin-1 were X-gal negative (A and B, arrows). Of note is the
finding that the typical visceral hyperplastic lesion positive for claudin-1 is connected to
the claudin-1 positive cells lining Bowman’s capsule (A, arrowhead). (C) X-gal and ASD33
immunofluorescence double staining showing costaining -gal expressing podocytes
with the podocyte marker antibody ASD33. The affected segment of the glomerulus is
negative for X-gal and ASD33 (C, asterisks). The merged images show a pseudocolor
overlay generated with Adobe Photoshop 7.0 (Adobe Systems Incorporated, San Jose,
CA). (D) X-gal staining showing rare X-gal positive cells that are present along the
periphery of glomerular lesions (D, arrows). (E, F) Immunohistochemical double staining
for claudin-1 and CD44 with X-gal revealed no costaining. The crescentic lesions were
positive for claudin-1 and CD44 but generally negative for X-gal (E and F, arrows).
Occasionally, involvement of podocytes within the lesion was observed (F, arrowhead).
Interestingly, in this particular lesion the podocyte seems to be attached to Bowman’s
capsule, a rare finding.
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Phenotype of Proliferating Cells in Crescentic
Glomerulonephritis
The cells involved in the crescentic lesions were examined in
more detail using immunofluorescence triple stainings.
First, the expression of CD44 was examined. As already ob-
served using immunohistochemistry (Figure 5), almost all
of the cells within crescentic lesions (as detected by Hoechst
counterstaining) expressed CD44. Furthermore, the CD44
staining colocalized with the PEC marker claudin-1, sup-
porting the notion that CD44 is a specific marker for acti-
vated PECs (Figure 6A). Double immunostaining for CD44
with the podocyte markers podocin and nephrin showed
that the lesion, positive for CD44, was negative for both
podocin and nephrin (Figure 6, B and C, respectively). Both
podocin and nephrin antibodies specifically stained the
podocytes. Of note, within the affected glomeruli, segmen-
tal to global reduction of the nephrin and podocin staining
was observed.
By double immunostaining for Ki-67 together with CD44
(Figure 6D) or with the podocyte marker nestin (Figure 6E), it
could be established that the CD44 positive cells account for
the majority of the proliferating cells, whereas only occasion-
ally double staining for Ki-67 and nestin could be observed.
Nestin staining specifically labeled podocytes and transitional
cells (podocyte progenitors) on Bowman’s capsule in normal
glomeruli,22 and in glomeruli with small crescentic lesions the
staining also was restricted to the glomerular tuft. In contrast,
in advanced crescentic lesions, nestin
staining was sometimes also present
within the glomerular tuft, crescent, and
periglomerular region. Therefore, the
origin of the rare nestin and Ki-67 posi-
tive cells cannot be resolved entirely.
Double immunostainings for bromode-
oxyuridine (BrdU) and claudin-1 con-
firmed that the PEC-derived cells within
the crescentic lesions exhibited a high
proliferation rate (Figure 6F).
To test whether infiltrating macro-
phages contribute to the formation of
the crescentic lesions as early as day 14
after CrGN induction, stainings for
CD68, a membrane antigen expressed
by macrophages and dendritic cells,
were performed. In costainings for col-
lagen IV, expressed within the basement
membranes of the glomerulus, CD68 ex-
pressing cells were present in the peri-
glomerular areas and alsowithin the glo-
merular tuft (Figure 6G, arrows). In
contrast, CD68 positive cells populating
the crescentic lesions were observed
rarely (Figure 6G, arrowhead). In this
regard, it is important to mention that
the Bowman’s capsules, stained by the
anti-collagen IV antibody, seemed to be still intact at this early
time point, because it has been shown that breaks in the cap-
sule correlate with an increase in the number of macrophages
in the cellular crescent.7,8
Tracing Genetically Tagged Parietal Epithelial Cells in
Collapsing Glomerulopathy
To examine the role of PECs in the development of CG, the
triple transgenic PEC-rtTA/LC1/R26R mouse was crossbred
with heterozygous Thy-1.1 transgenic mice. This resulted in
quadruple transgenic mice, in which PECs can be marked ge-
netically using doxycycline, and after a washout phase, CG can
be induced by a single injection of anti-Thy-1.1 mAb, which
binds to the Thy1.1 antigen ectopically expressed on podo-
cytes. The histopathology of this model shows a high resem-
blance to that of human CG, with collapse of the glomerular
tuft and development of proliferative lesions within 7 d after
the antibody injection.25 Crossbreeding of the Thy-1.1 mouse
with the PEC-rtTA mouse did not affect the phenotype of the
Thy-1.1 model (data not shown). After injection of an anti-
Thy 1.1 antibody, the PEC-rtTA/LC1/R26R/Thy-1.1 mice
acutely developed proteinuria within 1 h by dipstick analysis,
and CG lesions were noted within 7 d. On day 7, most of the
affected glomeruli showed a high degree of hypertrophy and
hyperplasia of epithelial cells in Bowman’s space, and many
showed segmental to global collapse of capillaries (Figure 7, A
and B). The hyperplastic cells formedmultilayered andmono-
Figure 5. PAS–CD44 double staining. (A) A still morphologically normal glomerulus in
the CrGN mouse that shows CD44 expression by PECs on Bowman’s capsule (A, arrows).
(B) A glomerulus containing a small pseudocrescent, which stains for CD44 (B, arrow). (C)
Large crescentic lesion showing a homogenous CD44 positive cell population in Bow-
man’s space. (D) True crescentic lesion with flattened cells that circumvent the glomerular
tuft. The cells forming the crescent stain for CD44.
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layer pseudocrescentic lesions that covered the glomerular
tuft. True crescents with flattened cells lining Bowman’s cap-
sule were observed infrequently. The histopathology resem-
bled that of the heterozygous Thy-1.1 transgenic mice de-
scribed in previous studies.25,26 Increased X-gal staining in
Bowman’s space was noted in most of the affected glomeruli.
X-gal positive cells populated cellular lesions covering glomer-
ular tuft segments (Figure 7, C andD). Similar to the lesions in
CrGN, these cells coexpressed the PECmarker claudin-1 (Fig-
ure 7E) and showed de novo expression of CD44 (Figure 7F).
CD44 was expressed by most if not all cells within the lesion.
The CD44 positive cells filling up Bowman’s space sometimes
directly covered the Thy-1.1 expressing podocytes (Figure 8).
DISCUSSION
In this study, PECs were traced for the first time in experimen-
tal CrGN and in CG using the novel approach of tagging either
of the two glomerular epithelial cell populations: PECs or
podocytes. This approach overcomes the issue of altered im-
munohistological characteristics of both podocytes and PECs
in disease situations, which has limited many studies on this
topic so far. Furthermore, an inducible transgenic system was
employed, ruling out any additional genetic labeling during
the experimental period.
As the first major finding of this study, we firmly establish
that PECs are the major cell population within cellular extra-
capillary lesions in the crescentic nephritis model. The low
number of CD68 expressing cells within the cellular lesions
indicates that in these early lesions there is a minor contri-
bution from the macrophages. A transition of podocytes to
macrophage-like cells, as observed by Barie´ty et al. in idio-
pathic CG, posttransplantation relapse of focal segmental
glomerulosclerosis, and CrGN11,27,28 were negligible in our
models.
The secondmajor finding was that PECs also constitute the
predominant cell population in proliferative cellular lesions in
amodel of CG. The findings of X-gal positive proliferating cells
in the present study provide direct evidence for the contribu-
tion of PECs in the formation of the CG lesions in the Thy-1.1
mouse model and are in line with the previously reported
marker studies performed in the Thy-1.1 transgenic mouse
Figure 6. Phenotype of proliferating cells (A) Double immuno-
fluorescence staining for claudin-1 (red) and CD44 (green). CD44
is de novo expressed by the cells forming the crescentic lesions.
Outside of the glomerulus, CD44 is expressed by a subpopulation
of the cells within the periglomerular fibrotic area and some
tubular cells. Within the crescentic lesions, the CD44 positive cells
costain with claudin-1 (A, arrows). (B, C) Double immunofluores-
cence staining for CD44 (green) and the podocyte markers podo-
cin (B) and nephrin (C). The proliferating cells filling up Bowman’s
space are positive for CD44 and negative for the podocyte mark-
ers. Note that the CD44 positive cells are positioned directly
against the podocin positive podocytes (B, arrow). The glomeru-
lar tufts of affected glomeruli showed segmental (B, arrowhead)
to a global (C, arrowhead) reduction in podocyte marker staining.
Panel C also shows a morphologically normal glomerulus showing
no CD44 staining and a normal nephrin staining (C, asterisks). (D)
Double immunofluorescence staining for CD44 (green) and the
proliferation marker Ki-67 (red). Many CD44 positive cells in the
periglomerular area and within the crescentic lesions express the
proliferation marker Ki-67. (E) Double immunofluorescence stain-
ing for nestin (green) and Ki-67 (red). Only rare nestin positive
cells show costaining with the proliferation marker Ki-67. The
majority of the Ki-67 positive cells were detected in the area
peripheral to the nestin positive cells. (F) Double immunofluores-
cence for the proliferation marker BrdU (red) and claudin-1
(green). The nuclei are counterstained with Hoechst to reveal
nuclei (blue). Many claudin-1 positive cells forming the cellular
lesion stain positive for BrdU. Together with the Hoechst staining,
BrdU positive cells show purple nuclei (arrows). The secondary
anti-mouse antibody used for the detection of the BrdU antibody
also recognized the endogenous mouse antibodies that bind to
the GBM (F, asterisks). (G) Double immunofluorescence staining
for collagen IV (green) and the macrophage marker CD68 (red).
The nuclei are counterstained with Hoechst (blue). The cells form-
ing the crescentic lesion do not express CD68 (G, asterisks). Many
CD68 positive cells were detected in the periglomerular areas
surrounding affected glomeruli and within the glomerular tuft (G,
arrows).
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model.25,26 In a parallel study on human biopsies,29 we also
found that proliferative lesions in patients with CrGN and CG
predominantly contained PECs. These hyperplastic cells were
identified by their expression of the renal progenitor markers
CD133 and CD24, similar to the cells on Bowman’s capsule.
Unfortunately, CD24 and CD133 cannot be used as a marker
for renal progenitor cells on Bowman’s capsule in mouse due
to interspecies differences.
In contrast to the prominent role for PECs in the prolifera-
tive lesions, we observed a relatively minor contribution of
genetically tagged podocytes in experimental CrGN. A simi-
larly minor contribution of podocytes also was described re-
cently in a study using lineage tracing of permanently tagged
podocytes in a model of CG.30
Nevertheless, the pathogenetic role of
podocytes within cellular lesions still re-
mains unresolved. Podocytes might be
displaced passively as innocent bystand-
ers into cellular lesions by the proliferat-
ing cells. Podocytes also might facilitate
PEC proliferation, because Le Hir et al.
observed that podocytes do not form in-
tercellular junctions with proliferating
PECs, which is necessary for antiprolif-
erative signals through “lateral contact
inhibition”.2 This also would be in line
with the notion that the PEC renal pro-
genitors from Bowman’s capsule prolif-
erate in the attempt to replace injured
podocytes. In the presence of extensive
podocyte damage, an abnormal attempt
of resident renal progenitors to regener-
ate injured podocytes could result in ex-
cessive proliferation, causing the forma-
tion of crescentic lesions.Whether some
of these proliferating cells succeed in dif-
ferentiating and replacing podocytes is
unknown. In the current study, the pro-
liferating cells in Bowman’s space were
lacking podocyte markers, arguing
against a differentiation of the cells. Be-
cause X-gal stainings are incompatible
with most immunostainings for podo-
cyte markers, it was impossible to study
whether any of the genetically tagged
cells on the tuft had differentiated into
podocytes. In our first report that podo-
cytes participate in the formation of cel-
lular crescents, podocyte-derived cells
were identified in a somewhat higher
percentage of glomeruli compared with
that in the present study (i.e., 52% versus
14% in the present study).10 Several rea-
sons could account for this difference.
First, in our initial study, podocyteswere
traced genetically using a less sophisticated transgenic model:
the double transgenic 2.5P-Cre/R26R mouse. In this mouse,
expression of Cre recombinase was driven constitutively by the
podocyte-specific podocin promoter. In this study, no signifi-
cant nephrin or podocin expression was detected in cellular
crescents, indicating that differentiation of transitional cells
toward a podocyte phenotype did not occur. However, in-
creased promoter activity may not always result in detectable
expression levels of protein. For example, the slit-diaphragm
protein podocin may be degraded, because these specialized
cellular structures are absent in cellular crescents. By use of the
transgenic doxycycline-inducible system in the present study
(PEC-rtTA and Pod-rtTA mice), this phenomenon was ex-
cluded definitely, because additional genetic labeling during
Figure 7. Genetically labeled PECs are present within the CG lesions. (A, B) PAS staining
of kidney sections at day 7 after the anti-Thy-1.1 mAb injection. The early lesions in the
PEC-rtTA/Thy-1.1 mice showed segmental to global collapse of the glomerular tuft,
hypertrophy and hyperplasia of the glomerular epithelial cells that resulted in the forma-
tion of pseudocrescents (A, arrow), and monolayer lesions on the glomerular tuft (B,
arrow). The arrowhead in panel A shows vacuoles and resorption droplets, a sign of
podocyte injury. The arrowhead in panel B shows a mitotic cell body in a monolayer
lesion. Protein casts were observed frequently in the tubular structures. In addition, many
proximal tubular cells contained protein resorption droplets (B, red arrow). (C, D) The CG
lesions stained positive with X-gal (C and D, arrows). (E, F) Double staining of X-gal with
claudin-1 and CD44, respectively. Within cellular lesions in Bowman’s space, X-gal pos-
itive cells costain with claudin-1 (E, arrow) and CD44 (F, arrow), whereas the cells of the
glomerular tuft remain negative for the PEC markers (E and F, asterisks).
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the experimental period in the absence of doxycycline is im-
possible.22 Second, a different (and potentially less active)
nephrotoxic serum in combination with a Toll-like receptor 9
agonist was used in this study.30 Third, even although the ge-
netic background of both transgenic mouse strains was simi-
larly mixed C57Bl6, there could have been more C57Bl6 in the
2.5P-Cre/R26R transgenic mice. In fact, we noticed that the
development of “true” crescents was more pronounced in the
previously used anti-GBM model compared with that in the
model used for the present study. Although genetically tagged
PECs were detected in both types of crescents in the present
study, our results suggested thatmorphological differences be-
tween pseudocrescents and true crescents correlate with differ-
ences in activity and developmental stage of the crescentic le-
sion.
The thirdmajor finding of this studywas the striking resem-
blance of themarker expression andmorphology of the lesions
in two entirely different models of glomerular disease, the
nephrotoxic nephritis and anti-Thy-1.1 CG, which closely re-
semble the human lesions found in CG. One of the resem-
blances in morphology was the development of pseudocres-
cents in both themodel of CrGN and the CG. Pseudocrescents
are typical lesions of CG and less often associated with CrGN.
However, so far most studies on human and experimental
CrGNmake no distinction between true and pseudocrescents.
Barie´ty et al. showed in a study of patients with anti-GBM
disease and class IV lupus glomerulonephritis that both types
of crescentic lesions were present in similar percentages.11 De-
spite the latter study, the epithelial cells
forming pseudocrescents have so far
mainly been investigated in humans or
experimental CG. The development of
pseudocrescents is believed to result
from podocyte dedifferentiation and
dysregulation leading to podocyte hy-
perplasia. The main argument for the
origin from podocytes was the visceral
location of the proliferating cells form-
ing the pseudocrescent14.15,27,28 In the
present study, it now has been demon-
strated unequivocally that in experi-
mental CrGN and CG pseudocrescents
including monolayer lesions located di-
rectly on top of the glomerular convo-
lute consisted of genetically tagged
PECs.
The resemblance in morphology and
marker expression in CG and CrGN
suggests that despite the different etiol-
ogies of both models PECs show a com-
mon response to the induced glomeru-
lar injury. Interesting in this regard is the
de novo expression of CD44, a glycopro-
tein involved in cell–cell interactions,
cell adhesion, andmigration in both CG
and CrGN. Also in human crescentic lesions found in biopsies
of patients with IgA nephropathy, de novo expression of CD44
was described.31 The de novo expression of CD44 in CrGN and
CG by PECs may point to a role for this adhesion molecule in
the activation migration of PECs.
Another common feature in both experimental CrGN and
CG and one of the earliest detectable changes in Bowman’s
space that has been reported in previous studies are cell bridges
between Bowman’s capsule and the glomerular convo-
lute2,16,25,32–34 In the present study, PEC lineage tracing enabled
us to identify bridging PECs that adhered to the glomerular
tuft. It is tempting to speculate that bridging of the PECs is a
critical process in the development of the hyperplastic lesions.
In this regard, understanding the processes involved in the
activation of PECs, bridge formation, and PEC proliferation
might provide targets for intervention to inhibit and even pre-
vent the formation of hyperplastic lesions and subsequent loss
of renal function.
CONCISE METHODS
Transgenic Mice
The generation of PEC-rtTA, POD-rtTA, LC1, R26R, and Thy1.1
transgenic mice was described previously.22,35–37 Animals were
housed under standard specific pathogen-free conditions. All animal
procedures were approved by the Landesamt fu¨r Natur, Umwelt und
Figure 8. Triple immunofluorescence staining for CD44, Thy-1.1, and heparan sulfates
(HS). The HS panel, in which the glomerular basal membranes are stained with an
antibody directed against heparan sulfates, shows a glomerulus with a collapsed glomer-
ular tuft. The epithelial cells in Bowman’s space show expression of CD44. Only at the
margin of the glomerular tuft we sometimes observed colocalization of CD44 and the
Thy-1.1 antigen expressed by podocytes, indicating that the Thy1.1 positive podocytes
are covered directly with the CD44 positive cells of the lesion.
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Verbraucherschutz Nordrhein-Westfalen (8.87–50.10.35.08.106;
8.87–50.10.35.08.254, and 50.203.2—AC 10/06).
Doxycycline Treatment
The PEC-rtTA, POD-rtTA, and PEC-rtTA/Thy-1.1 animals received
doxycycline hydrochloride via the drinking water ad libidum for a
total of 14 d (5% sucrose and 0.5 mg of doxycycline per milliliter,
protected from light), which was exchanged every 2 d. To be sure that
the mice are free from doxycycline during the experimental proce-
dures, themice received normal drinking water ad libdtum for at least
7 d.
Animal Experiments
Seven-week-old POD-rtTA (n  10) and PEC-rtTA (n  10) mice
received a single intraperitoneal injection of 0.8 ml of sheep anti-
mouse nephrotoxic30 serum spiked with 40 g of CpG oligonucleo-
tides. The proteinuria and hematuria were checked every 2 d by dip-
stick analysis (Roche, Basel, Switzerland). After 14 d, the mice were
killed, and the kidneys were collected.
Seven-week-old PEC-rtTA/LC1/R26R/Thy-1.1 crossbreeds (n 
5) received an intravenous injection with 2 mg of anti-Thy-1.1 mAb
(19XE5) in 0.1ml of 0.9% saline solution. The proteinuria and hema-
turia were checked daily by dipstick analysis. Kidney samples were
collected at day 7 after anti-Thy-1.1 mAb injection.
Perfusion Fixation
Mice were anesthetized (ketamine/rompun). The blood vessels to-
ward and from the left kidney were clamped, and the left kidney was
removed. Subsequently, the right kidney was perfused via the left
heart ventricle with perfusion solution (3% paraformaldehyde, 0.2%
glutaraldehyde, 2.5 mM EGTA, and 4 mM MgCl2 in 0.5 PBS, pH
7.6) for 3 min. Pieces of both kidneys were snap-frozen in liquid
nitrogen or (post)fixed in 3% buffered formalin and embedded in
paraffin.
Light Microscopy
For light microscopy, kidney fragments were fixed in 3% buffered
formalin, dehydrated, and embedded in paraffin. Four-micrometer
sections were stainedwith PAS. To obtain the percentage of glomeruli
containing lesions, at least 60 glomeruli per mouse were evaluated for
the presence of hypertrophy and hyperplasia of the glomerular epi-
thelium, adhesions, sclerosis, or hyalinosis. Crescentic lesions were
defined as cellular structures made of two or more cell layers in the
urinary space. True crescents were distinguished from pseudocres-
cents.11 In true crescents, the epithelium lining Bowman’s capsule is
replaced by several cell layers, and Bowman’s space often is obliter-
ated, either segmentally or circumferentially by these proliferating,
flattened cells.
Pseudocrescents consist of cuboidal, polygonal cells proliferating
close to the glomerular tuft and not necessarily lining Bowman’s cap-
sule. Often, there remains some free Bowman’s space.
In addition to the multilayered crescentic lesions, monolayer le-
sions were observed that consisted of one layer of proliferating cells
located directly on the glomerular tuft. Also monolayer lesions were
classified as pseudocrescents.
-Galactosidase Detection
-Gal activity was detected using enzymatic X-gal or Bluo-gal stain-
ing. For this purpose, 4- to 6-m cryosections were incubated over-
night at 37°C in a humidified atmosphere in staining solution (1
mg/ml X-gal or Bluo-gal, 5 mM potassium ferricyanide, 5 mM potas-
sium ferrocyanide, and 2mMMgCl2 in PBS, pH7.8).On the next day,
samples were either counterstained with eosin, washed in tap water,
and mounted (Immu-Mount, Thermo Scientific, Waltham, MA) or
further processed for immunofluorescence or immunohistochemis-
try (see below).
Immunofluorescence
The immunofluorescence stainings were performed on 2- or 4-m
cryosections. The sections were fixed in 20°C acetone with the ex-
ception of the sections used for the double stainings with X-gal and
stainings for BrdU (see below). For double labeling with X-gal, im-
munofluorescence staining was performed on the X-gal stained sec-
tions (see Concise Methods, “-Galactosidase Detection”). The BrdU
stainingwas performedon 3%buffered paraformaldehyde fixed cryo-
sections. Prior to the immunostaining, the sections were incubated in
2 N HCl solution at 37°C for 30 min and subsequently neutralized in
borate buffer.
For the single and double immunofluorescence staining, the sec-
tions were incubated with the following primary antibodies: rabbit
anti-claudin-1, chicken anti-nestin, mouse anti-BrdU, and rabbit an-
ti-collagen IV (Abcam, Cambridge, UK), rabbit anti-podocin P0372
(SigmaAldrich, St. Louis,MO), rabbit anti-nephrin (kind gift of Larry
Holzman, University of Pennsylvania, Philadelphia), rat anti-CD44,
(R&D Systems, Minneapolis, MN), rabbit anti-mouse Ki-67 (Di-
anova Immundiagnostic, Hamburg, Germany), rat anti-mouse CD68
(clone FA-11, Serotec, Oxford, UK), rat anti-aminopeptidase A
(ASD41),38 and rat anti-ASD33 (ASD33).38 The following secondary
antibodies were used: goat anti-rabbit Dylight 549 (1:100 #35557,
Pierce Biotechnology, Rockford, IL), Alexa Fluor 488-conjugated
goat anti-rabbit, Alexa Fluor 488-conjugated anti-rat, Alexa Fluor
568-conjugated anti-rat IgG, and Alexa Fluor 488-conjugated anti-
mouse IgG (MoBiTech, Goettingen, Germany), and carbocyanine
2-conjugated donkey anti-chicken IgG (Jackson ImmunoResearch
Laboratories). All secondary antibodies, except the anti-mouse anti-
body, were immuno-absorbed with 4% normal mouse serum. The
nuclei were stained using a Hoechst 33342 (Sigma Aldrich, St Louis,
MO). Sections were evaluated with an Olympus BX 41 microscope.
Imageswere collectedwithAnalySIS (Soft Imaging System,Muenster,
Germany).
Triple immunofluorescence staining was performed on 2-m ac-
etone-fixed cryosections. The sections were incubated with the fol-
lowing primary antibodies: mouse anti-mouse Thy-1.1 mAb (19XE5,
subclass IgG3),25 rat anti-CD44, (R&D Systems, Minneapolis, MN),
and an anti-heparan sulfate single-chain antibody HS4E4.39 The fol-
lowing secondary antibodies were used: Alexa Fluor 647-conjugated
anti-mouse IgG3, Alexa Fluor 568-conjugated anti-rat IgG (Mo-
BiTech, Goettingen, Germany), and the single-chain antibody were
detected with a carbocyanine 2-labeled rabbit antibody directed
against the vesicular stomatitis virusG epitope tag (Sigma-Aldrich, St.
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Louis, MO). The sections were examined with a confocal laser scan-
ning microscope (Leica Lasertechnik GmbH, Heidelberg, Germany).
Immunohistochemistry
For double labeling of claudin-1 with X-gal or Bluo-gal, 4-mkidney
X-gal or Bluo-gal stained sections (see Concise Methods, “-Galacto-
sidase Detection”) were processed for immunohistochemistry. The
sections were blocked for endogenous avidin/biotin (Avidin/Biotin
Blocking Kit, Vector Laboratories, Burlingame, CA) and peroxidase
activity (3%H2O2). Subsequently, the sections were incubated with a
rabbit anti-claudin-1 antibody (Abcam, Cambridge, UK) or rat anti-
CD44 (BD Pharmingen, Franklin Lakes, NJ). As a secondary anti-
body, a biotinylated goat anti-rabbit or goat anti-rat antibody was
used (Vector Laboratories, Burlingame, CA). Detection was carried
out with Vectastain ABC Kit (Vector Laboratories, Burlingame, CA)
with the use of peroxidase as a label and 3-amino-9-ethylcarbazole as
a substrate. Images were acquired using an Olympus BX 41 micro-
scope. Images were collected with AnalySIS.
To establish whether CD44 expression correlated with the pres-
ence of a crescentic lesion, we performed CD44 immunostaining on
4-m paraffin sections. The sections were subjected to microwave
antigen retrieval in Antigen Unmasking Solution (Vector Laborato-
ries, Burlingame, CA) followed by the immunostaining as described
above. Subsequently, the sections were stained with PAS). CD44
staining was assessed in four mice at day 14 after CrGN induction. At
least 70 glomeruli with crescentic lesions were examined per mouse.
To quantify the relative contributions of podocytes and PECs to
the development of the crescentic lesions, we examined double stain-
ing of X-gal and CD44 in POD-rtTA (n 4) and PEC-rtTA (n 4)
mice. We quantified the percentage of CD44 positive crescentic lesions
that contained X-gal stained podocytes or PECs. At least 30 glomeruli
containing a CD44 positive crescent per mouse were examined.
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